Thomson Medical Group Limited (A50.SI)

Thomson Medical Group Limited (A50.SI) — VMCI valuation read

Thomson Medical Group Limited sits at VMCI 34/100, with the Healthcare sector median at 50. That 16-point spread is the first thing to note on A50.SI: it tells the reader the composite is unfavorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on A50.SI are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on A50.SI: A50.SI trades at 26.0x earnings, 44% above the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 16.0% sits 6.0pp above the Healthcare median (10.0%). The Risk read: net debt to EBITDA of 0.3x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.

A50.SI rose 3.3% over the trailing 7 days, with a -0.4% read on a 30-day basis.